NGM Bio today announced multiple milestones for NGM282, an experimental medicine for the treatment of NASH. The company confirmed that results from an exploratory 12-week Phase 2 clinical trial of...

AliveCor, the leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced findings from two new studies that further support the use of its portable ECG devices to provide...

Ho Chi Minh City drew thousands of blockchain enthusiasts in search of knowledge during Vietnam Blockchain Week, causing a major hotel room shortage. These enthusiasts came from various...

The United States Patent and Trademark Office (USPTO) today unveiled the new design of the patent grant cover during a special ceremony at the South by Southwest (SXSW) Interactive Festival in...

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results of a new analysis showing that INVOKANA® (canagliflozin) significantly reduced the risk of cardiovascular (CV)...